Get In Touch

Neonatal conjunctivitis, also known as ophthalmia neonatorum, is one of the causes of severe neonatal morbidity as well as mortality in developing countries. Neonatal conjunctivitis is defined as conjunctivitis that occurs in newborns mostly during the first few days of life. Clinical signs of the disease include edema, erythema of the eyelids, and purulent discharge from the eyes. Agents of sexually transmitted diseases (STDs) such as Neisseria gonorrhoeae and Chlamydia trachomatis are some of the etiologic agents of neonatal conjunctivitis. Microorganisms that occur on the skin and in the gastrointestinal tract such as Staphylococcus aureus and Pseudomonas sp. can also cause the disease. The cause of neonatal conjunctivitis is difficult to determine.

The global neonatal conjunctivitis treatment market is expect to expand at a significant CAGR during the forecast period. Neonatal conjunctivitis leads to blindness in babies across the world. Rising prevalence of neonatal conjunctivitis in developing countries is one of the factors driving the global market during the forecast period. Surge in the prevalence of sexually transmitted diseases (STDs) is another factor likely to propel the global market during the forecast period. Factors such as poor hygiene conditions, premature deliveries, and maternal sexually transmitted infection are some of the risk factors for neonatal conjunctivitis. Lack of awareness about the treatment of the disease in developing countries and lack of coverage of medicines in these countries are some of the factors restraining the global neonatal conjunctivitis treatment market during the forecast period.

The global neonatal conjunctivitis treatment market can be segmented based on causative agent, distribution channel, and region. Based on causative agent, neonatal conjunctivitis treatment market has been divided into neonatal conjunctivitis caused by Chlamydia, neonatal conjunctivitis caused by Neisseria, neonatal conjunctivitis caused by viruses, and others. The most common cause of neonatal conjunctivitis is Chlamydia. Hence, the neonatal conjunctivitis caused by Chlamydia segment is anticipated to hold a significant share of the global neonatal conjunctivitis treatment market during the forecast period. Based on distribution channel, the global neonatal conjunctivitis treatment market has been divided into hospital pharmacies, drug stores, and online pharmacies. The hospital pharmacies segment is anticipated to the hold the largest share of the global Cellular Therapy in Oncology Pipeline market during the forecast period. 

Geographically, the global neonatal conjunctivitis treatment market has been divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global market for neonatal conjunctivitis. High prevalence of sexually transmitted diseases (STDs) and rise in awareness about neonatal conjunctivitis are some of the key factors driving neonatal conjunctivitis treatment market in North America. Furthermore, rise in awareness among people about ocular drug delivery systems, rise in per capita health care expenditure, increase in R&D of new drugs are fueling the market in the region. Europe is anticipated to hold the second-largest share of the global neonatal conjunctivitis treatment market from 2017 to 2025, due to rise in the incidence of gonorrhea infection in the region. Neonatal conjunctivitis treatment market in Asia Pacific is anticipated to witness rapid growth during the forecast period. Asia Pacific is a highly lucrative market for neonatal conjunctivitis treatment, due to increase in the prevalence of infections, poor hygiene conditions in developing countries, and prolonged deliveries in some of the countries in the region.

In order to acquire a significant position in neonatal conjunctivitis treatment market, key players in the global neonatal conjunctivitis treatment market have adopted strategies such as mergers and acquisitions, improvement in products, and cost-effectiveness. Some of the key players operating in the global neonatal conjunctivitis treatment market are Merck & Co. Inc., Akorn Inc., Pfizer Inc., and Bayer AG.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Neonatal Conjunctivitis Treatment Market

Pre Book